Inhibitors of neutrophil mediated oxidant production

Details Inhibitors of neutrophil mediated oxidant production Inhibitors of neutrophil mediated oxidant production

A - Human Necessities

61

K

A61K 31/535 (2006.01) A61K 31/16 (2006.01) A61K 31/165 (2006.01) A61K 31/195 (2006.01) A61K 31/34 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/4045 (2006.01) A61K 31/44 (2006.01) A61K 31/4439 (2006.01) A61K 31/445 (2006.01) A61K 31/4453 (2006.01) A61K 31/4525 (2006.01) A61K 31/454 (2006.01) A61K 31/4545 (2006.01) A61K 31/47 (2006.01) A61K 31/4725 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) A61K 31/55 (2006.01)

Patent

CA 2295697

This invention provides methods for treating diseases and disorders associated with an excess of neutrophil mediated oxidant production.

Cette invention concerne des procédés permettant de traiter des maladies et troubles associés à une production excédentaire d'oxydant induite par des neutrophiles.

Affiliated with

Also associated with

Rating

Inhibitors of neutrophil mediated oxidant production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of neutrophil mediated oxidant production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of neutrophil mediated oxidant production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2063452